Cephalexin
NDC Package 64205-101-14
Package Information
Cephalexin is a medication used to treat a wide variety of bacterial infections. Marketed by Readymeds, this product is identified by NDC 64205-101 and is authorized under FDA application ANDA062713.
Identification & Billing
- RxCUI: 309112 - cephalexin 250 MG Oral Capsule
- RxCUI: 309112 - cephalexin (as cephalexin monohydrate) 250 MG Oral Capsule
- RxCUI: 309114 - cephalexin 500 MG Oral Capsule
- RxCUI: 309114 - cefalexin (as cefalexin monohydrate) 500 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 64205 - Readymeds
- 64205-101 - Cephalexin
- 64205-101-14 - 14 CAPSULE in 1 BOTTLE
- 64205-101 - Cephalexin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64205-101-14 identifies a specific commercial package of 14 capsule in 1 bottle of Cephalexin, labeled by Readymeds. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Readymeds on January 12, 2012. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.
How is this Readymeds product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64205010114. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.